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A 43-year-old woman, who was a non-smoker and who had been previously identified as having malignant pericardial effusion and a PET scan suggestive of a primary malignant tumour in the left upper lobe of the lung with mediastinal lymphadenopathy was referred to the emergency department at the University Hospital Centre Zagreb in December, 2012, because of progressive dyspnoea. Chest radiography obtained on admission showed substantial enlargement of the cardiac silhouette. Echocardiography pointed to pre- adenocarcinoma. An initial test of pericardial effusion showed adenocarcinoma cells that were CK7 and TTF-1 positive and CK20 negative, which is compatible with a diagnosis of primary pulmonary adenocarcinoma. Molecular testing showed positive EGFR mutation (exon 19 deletion). The patient received 150 mg erlotinib once-daily, and her overall survival was 30 months.
Contributors
DM, MK and SB were clinicians in management of the patient's malignant pericardial effusion. MM interpreted medical images. MJ and MS were consultants in the patient's care.
All authors contributed to the preparation and writing of the manuscript and approved the final manuscript.
Declaration of interests
The authors declared no conflicts of interest. 
